Skip to main content
logo
Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.290
+0.020 (1.57%)
At close: Sep 14, 2026, 4:00 PM EDT
1.300
+0.010 (0.78%)
After-hours: Sep 14, 2026, 4:22 PM EDT

Caribou Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
138149144507383908
Market Cap Growth
-16.57%3.22%-71.59%32.27%-57.82%-
Enterprise Value
5115-11013768473
Last Close Price
1.271.591.595.736.2815.09

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
14.0513.3214.4114.7027.6694.63
PB Ratio
1.371.220.571.381.272.34
P/TBV Ratio
1.441.220.571.381.272.34

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.361.33-3.994.9449.28

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.270.220.110.070.09-
Net Debt / Equity Ratio
-0.89-0.95-0.88-0.94-0.96-1.07
Net Debt / EBITDA Ratio
0.830.891.373.072.766.27
Net Debt / FCF Ratio
0.911.031.563.292.9711.94
Asset Turnover
0.060.050.030.090.030.04
Quick Ratio
6.365.606.9411.768.9714.87
Current Ratio
6.495.727.1611.979.2515.15
Return on Equity (ROE)
-78.27%-78.97%-47.99%-30.50%-28.87%-32.99%
Return on Assets (ROA)
-36.84%-34.26%-27.94%-18.00%-16.30%-17.50%
Return on Capital Employed (ROCE)
-85.90%-89.30%-58.90%-28.70%-30.80%-16.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-73.35%-99.67%-103.56%-20.14%-25.95%-7.37%
FCF Yield
-67.92%-75.60%-99.38%-20.70%-25.43%-3.81%
Buyback Yield / Dilution
-4.73%-3.40%-22.37%-21.39%-92.02%-270.47%
SEC Filings: 10-K · 10-Q